Last reviewed · How we verify
NCT04477837
Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
trial testing Apixaban 5 MG in Heavy Menstrual Bleeding in 84 participants. Completed in 15 June 2024.
31 May 2024
Quick facts
| Lead sponsor | Cardioangiologisches Centrum Bethanien |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 84 |
| Start date | 15 October 2020 |
| Primary completion | 31 May 2024 |
| Estimated completion | 15 June 2024 |
| Sites | 1 location across Germany |
Drugs / interventions tested
- Apixaban 5 MG — full drug profile →
- Rivaroxaban 20 MG — full drug profile →
- Edoxaban 60 MG — full drug profile →
- Dabigatran 150 Mg Oral Capsule
Conditions studied
- Heavy Menstrual Bleeding — all drugs for Heavy Menstrual Bleeding →
Sponsor
Cardioangiologisches Centrum Bethanien
Who can join
Adults 18 to 50, female only, with Heavy Menstrual Bleeding. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Prospective comparison of the incidence of heavy menstrual bleeding (HMB) in women of reproductive age treated with direct oral anticoagulants (DOACs)
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04477837
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Apixaban 5 MG
Trials testing the same drug.
- NCT04278729 — A Prospective Multi-dose Study of Apixaban in Subjects With Nephrotic Syndrome · Phase 1 · completed
- NCT04142658 — PROACT Xa - A Trial to Determine if Participants With an On-X Aortic Valve Can be Maintained Safely on Apixaban · Phase 3 · terminated
- NCT03692065 — API-CAT STUDY for APIxaban Cancer Associated Thrombosis · Phase 3 · completed
- NCT03083704 — A Healthy Volunteer PK/PD, Safety and Tolerability Study of Second Generation Andexanet Alfa · Phase 1 · completed
Other recruiting trials for Heavy Menstrual Bleeding
Currently open trials in the same condition.
- NCT07326722 — Delivering tAN to Reduce HMB: The LUNA Study · NA · recruiting
- NCT06634719 — Juveena Hydrogel System Feasibility Study for Heavy Menstrual Bleeding (HMB) · NA · recruiting
- NCT06671548 — Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids · Phase 3 · recruiting
- NCT05922657 — A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device · recruiting
- NCT06921629 — Menstrual Complaints in Adolescents and Adults · active not recruiting
Other Cardioangiologisches Centrum Bethanien trials
Trials by the same sponsor.
- NCT07390214 — REFOCUS-AF - "RepEat Ablation With AFFERA vs. COntact Force-Guided RF Catheters for Optimal OUtcomes in Symptomatic AF". · NA · recruiting
- NCT07459387 — REal-world Valued Outcomes of a noveL Balloon-in-basket pUlsed Field ablaTION Catheter for Atrial Fibrillation RegistrY · NA · recruiting
- NCT06403527 — Ultrasound Guyded Venous Puncture for Safe AF Ablation Procedures · NA · terminated
- NCT07385417 — Electroporation Treatment for Early AF Management in Heart Failure With Preserved Ejection Fraction (HFpEF) Pilot Study · NA · recruiting
- NCT05313048 — Prospective Observational Study to Evaluate a Possible Change in APS Antibody Profiles After COVID-19 Infection or Vacci · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04477837 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cardioangiologisches Centrum Bethanien
- Last refreshed: 21 August 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04477837.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing